✦ LIBER ✦

Risk-Benefit Profile for Raloxifene: 4-Year Data From the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial

✍ Scribed by Elizabeth Barrett-Connor; Jane A Cauley; Pandurang M Kulkarni; Andreas Sashegyi; David A Cox; Mary Jane Geiger

Book ID: 111485091
Publisher: American Society for Bone and Mineral Research
Year: 2004
Tongue: English
Weight: 90 KB
Volume: 19
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.040406

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Raloxifene and cardiovascular events in

Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

✍ E. Barrett-Connor; D. Grady; A. Sashegyi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Associations Between Baseline Risk Facto

Associations Between Baseline Risk Factors and Vertebral Fracture Risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study

✍ Olof Johnell; John A Kanis; Dennis M Black; Adam Balogh; Gyula Poor; Somnath Sar 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 130 KB

Post hoc analysis of data from the Multi

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

✍ Elizabeth Barrett-Connor; Kristine E. Ensrud; Kristine Harper; Timothy M. Mason; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 876 KB